CCM
ABMD

Cadence Capital Management’s Abiomed Inc ABMD Stock Holding History

Cadence Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-9,620
Closed -$868K – 675
2015
Q4 		$868K Buy
+9,620
New +$816K 0.06% 336

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Cadence Capital Management's ABMD Position: Q1 2016 in Review

Cadence Capital Management sold out of Abiomed Inc (ABMD) in Q1 2016, closing a stake of 9,620 shares — an estimated $868K sold.

Cadence Capital Management first reported a position in ABMD in Q4 2015 and held it in 1 quarter. The position peaked at $868K in Q4 2015. 274 funds tracked by Wall St. Rank hold ABMD as of Q1 2016.

  • Cadence Capital Management reported no remaining Abiomed Inc position as of Q1 2016 after selling out during the quarter.
  • Cadence Capital Management sold 9,620 Abiomed Inc shares in Q1 2016, an estimated $868K.
  • Cadence Capital Management first reported a position in Abiomed Inc in Q4 2015 and held it in 1 quarter.
  • Cadence Capital Management's Abiomed Inc position peaked at $868K in Q4 2015.
  • 274 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2016.

Based on Cadence Capital Management's 13F filing for Q1 2016, filed 2 May 2016.